NDIA Board Meeting of 27 March 2024 - 6. Corporate Plan Key Activity 2: Improving participant experience and outcomes with a financially sustainabl…
DOCUMENT 13
OFFICIAL: SENSITIVE
The contents of this document are OFFICIAL: SENSITIVE
| Board meeting: | 27 March 2024 |
| Agenda Item: | 6.2 |
| Agenda Item: | Annual Pricing Review updates & considerations |
| Paper Type: | For Discussion |
redacted: s22(1)(a)(ii) - irrelevant material
4.2. Therapy supports: Initial analyses indicate the number of active registered providers has decreased (a 16% reduction in the 6 months to December 2023 compared to a year ago), with a greater increase to active unregistered providers. Preliminary findings on the
OFFICIAL: SENSITIVE
6.2.1
Page 82 of 134 179
NDIA Board Meeting of 27 March 2024 - 6. Corporate Plan Key Activity 2: Improving participant experience and outcomes with a financially sustainabl…
OFFICIAL: SENSITIVE
comparison of market and other government schemes suggest that NDIS therapy price limits may be on par or lower for certain types of therapies.
redacted: s22(1)(a)(ii) - irrelevant material
OFFICIAL: SENSITIVE
6.2.2
Page 83 of 134 180
NDIA Board Meeting of 27 March 2024 - 6. Corporate Plan Key Activity 2: Improving participant experience and outcomes with a financially sustainabl…
OFFICIAL: SENSITIVE
redacted: s22(1)(a)(ii) - irrelevant material
7.4. There has also been heightened criticisms from some sector stakeholders in the pricing approach given price limits for some provider groups (therapy, support coordination and plan management) have not been increased for 4 to 5 years. However benchmarking data (in relation to therapy prices), as well as data relating to market entries and exits (across all these providers) have provided support for the decisions previously made. Early evidence suggests that the picture is less clear cut this year.
redacted: s22(1)(a)(ii) - irrelevant material
OFFICIAL: SENSITIVE
6.2.3
Page 84 of 134 181